2021 KUMC Virtual Multidisciplinary Oncology Review
Playback speed
10 seconds
mCRC Updates: FOLFOXIRI+Bev for Unresectable Disease, CEND-1+Neoadjuvant FOLFIRINOX, CRS-HIPEC for Colorectal Peritoneal Carcinomatosis, Oligometastatic Disease
41 views
May 17, 2021
Comments 0
Login to view comments.
Click here to Login
Videos